文献速递慢阻肺呼吸危重症与机械通气

经鼻高流量氧疗未改善COPD急性加重恢复期患者的运动耐力:一项随机交叉研究

Nasal high flow does not improve exercise tolerance in COPD patients recovering from acute exacerbation: A randomized crossover study.
PubMed 文献 · Respirology · 2019-08-06

本研究为单中心随机对照交叉试验,纳入19例重度至极重度COPD急性加重恢复期患者,在连续两天分别于使用和不使用经鼻高流量氧疗(NHF)条件下进行高强度恒功率运动试验。结果显示NHF未显著延长运动耐力时间,且半数患者认为该装置中度至非常不舒适。

要点

  • NHF未显著改善COPD急性加重恢复期患者的恒功率运动耐力时间。
  • NHF运动结束时股外侧肌氧饱和度、经皮CO2分压和心率较对照条件降低。
  • 半数患者评价NHF装置为中度至非常不舒适。

核心结论

  • 运动时使用NHF未增加COPD急性加重后患者的耐力时间。

研究设计与样本

  • 单中心、随机、对照交叉研究,纳入19例重度至极重度COPD急性加重恢复期患者。
  • 患者在连续两天分别于使用和不使用NHF条件下完成两次高强度恒功率运动试验(CWRET)。
  • 主要结局为两种条件下耐力时间的平均差异。

主要发现

  • 两种条件下CWRET耐力时间无显著差异(-66.58 s,95%CI:-155.9至22.7,P=0.12)。
  • NHF运动结束时股外侧肌氧饱和度降低-2.1%(95%CI:-4.3至-0.0)。
  • NHF运动结束时经皮CO2分压降低-1.3 mm Hg(95%CI:-2.5至-0.2)。
  • NHF运动结束时心率降低-2.7 bpm(95%CI:-5.0至-0.5),P≤0.05。
  • 其他次要结局均无显著差异,半数患者评价装置为中度至非常不舒适。

临床怎么用

  • 对于COPD急性加重恢复期患者,运动时常规使用NHF以改善运动耐力的依据不足。
  • 需结合患者对NHF装置舒适度的个体感受决定是否使用。

局限性

  • 单中心研究,样本量较小(19例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: We hypothesized that by reducing respiratory work and improving gas exchange, nasal high flow (NHF) would improve exercise tolerance in patients with chronic obstructive pulmonary disease (COPD) following respiratory exacerbation. METHODS: This was a monocentric, randomized, controlled crossover study. Patients with severe to very severe COPD carried out two high-intensity constant work-rate exercise tests (CWRET) with and without NHF on two consecutive days. The primary outcome was the mean difference in endurance time between both conditions. The secondary aims included vastus lateralis oxygenation (StO2 ), dyspnoea, leg discomfort, maximal inspiratory pressure (MIP), transcutaneous CO2 pressure (PtcCO2 ), respiratory rate (RR), heart rate (HR) and pulsed O2 saturation (SpO2 ), as well as the patients' opinions of the device. RESULTS: A total of 19 patients were included (mean forced expiratory volume in 1 s = 28.7 ± 10.8%, age = 62.1 ± 9.1 years). No significant differences in endurance time during the CWRET were found between the two test conditions (-66.58 (95% CI: -155.9 to 22.7) s, P = 0.12). StO2 , PtCO2 and HR were reduced at the end of the exercise with NHF (-2.1% (95% CI: -4.3 to -0.0); -1.3 mm Hg (95% CI: -2.5 to -0.2); -2.7 bpm (95% CI: -5.0 to -0.5), respectively, P ≤ 0.05). No significant differences were found for any of the other secondary outcomes. Half of the patients evaluated the device as being moderately to very uncomfortable. CONCLUSION: NHF during exercise did not increase endurance time in patients with COPD following exacerbation. CLINICAL TRIAL REGISTRATION: NCT03058081 at clinicaltrials.gov.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Prieur G, Medrinal C, Combret Y, et al. Nasal high flow does not improve exercise tolerance in COPD patients recovering from acute exacerbation: A randomized crossover study. Respirology. 2019. PMID: 31387158. doi:10.1111/resp.13664

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。